Gradual Tapering of Sertraline to Minimize Discontinuation Syndrome

Identification of Discontinuation Risk

Sertraline is recognized as an SSRI that commonly produces discontinuation syndrome; a gradual dose reduction is therefore recommended to lessen withdrawal risk. [1][2]

Reduce the dose by 25–50 mg every 1–2 weeks for the initial phase of tapering. This stepwise approach applies to doses from 300 mg down to 150 mg. [1][2]
When the dose falls below 150 mg, switch to 25 mg decrements every 1–2 weeks to provide finer control as the therapeutic threshold is approached. [1][2]
For doses below 50 mg, extend the interval between reductions to 2–4 weeks to further minimize symptom emergence. 3
The overall taper should span several weeks to months, allowing sufficient time for the nervous system to adapt at each step. [3][4]
General tapering principles derived from hypnotic discontinuation recommend using the smallest possible dose decrement and maintaining each step for at least several days, often requiring weeks to months to achieve a successful discontinuation. 3

Discontinuation symptoms typically appear within 24–48 hours after a dose reduction. [1][2]
Somatic symptoms to watch for include dizziness, fatigue, muscle aches, chills, headache, nausea, vomiting, diarrhea, insomnia, balance problems, vertigo, sensory disturbances, and paresthesias. [1][2]
Psychological symptoms may include anxiety, irritability, agitation, and crying spells. [1][2]

If moderate or severe withdrawal symptoms develop, extend the interval between dose reductions to 2–4 weeks before proceeding with further tapering. 3

Some individuals experience protracted withdrawal (e.g., dysphoria, irritability, insomnia, anhedonia) lasting months after complete discontinuation; these require recognition and supportive care. 4
Plan a minimum taper duration of 8–12 weeks, with the possibility of extending to 4–6 months for optimal tolerability in many patients. [3][4]

Longer tapers of approximately 10 % of the dose per month—or slower—are better tolerated in individuals who have been on sertraline for ≥ 1 year, according to the 2022 MMWR Recommendations. 5

The taper may be paused and later restarted when the patient feels ready, as recommended by the 2022 MMWR Guidelines. 5

Patients should be monitored at least once per month throughout the tapering period, per the 2022 MMWR Recommendations. 5

During periods of heightened withdrawal symptoms, more frequent contact—such as telephone calls, telehealth visits, or in‑person appointments—may be necessary, according to the 2022 MMWR Guidelines. 5